Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 350
Single User License Price INR 24917
Corporate User License Price USD 1050
Corporate User License Price INR 74750
Site License Price USD 700
Site License Price INR 49833
Request a Quote

Report Title

Pharmaceuticals in Asia-Pacific

Quote Request for License Type
License Type Price  
Single User License USD 350
Site License USD 700
Enterprise Wide License USD 1050
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Pharmaceuticals in Asia-Pacific


Quote Request for License Type
License Type Price  
Single User License USD 350
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Pharmaceuticals in Asia-Pacific

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Pharmaceuticals in Asia-Pacific



Executive Summary

Pharmaceuticals in Asia-Pacific

Summary

Pharmaceuticals in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Asia-Pacific pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.

- The Asia-Pacific pharmaceuticals market had total revenues of USD 291.0bn in 2017, representing a compound annual growth rate (CAGR) of 6.4% between 2013 and 2017.

- Countries such as China, India and Indonesia are experiencing strong growth due to a bourgeoning middle class which spend more on health and greater awareness of chronic diseases.

- South Korea and Japan contrast the performance of the region as a whole. Low rates of growth show those markets are mature and pressure is exerted on leading pharmaceutical companies to keep costs down amid greater demands being placed upon the healthcare system.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Asia-Pacific

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Asia-Pacific

- Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific pharmaceuticals market with five year forecasts

Reasons to buy

- What was the size of the Asia-Pacific pharmaceuticals market by value in 2017?

- What will be the size of the Asia-Pacific pharmaceuticals market in 2022?

- What factors are affecting the strength of competition in the Asia-Pacific pharmaceuticals market?

- How has the market performed over the last five years?

- Who are the top competitiors in Asia-Pacific's pharmaceuticals market?

Table of Contents

Executive Summary 2

Market value 2

Market value forecast 2

Geography segmentation 2

Market share 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 9

Market value 9

Market Segmentation 10

Geography segmentation 10

Market share 11

Market Outlook 12

Market value forecast 12

Five Forces Analysis 13

Summary 13

Buyer power 15

Supplier power 17

New entrants 18

Threat of substitutes 20

Degree of rivalry 21

Leading Companies 23

Daiichi Sankyo Co Ltd 23

Shanghai Pharmaceutical Co Ltd 26

Takeda Pharmaceutical Company Limited 29

Yangtze River Pharmaceutical Group 32

Methodology 33

Industry associations 34

Related MarketLine research 34

Appendix 35

About MarketLine 35

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Figure 1: Asia-Pacific pharmaceuticals market value: USD billion, 2013-17

Figure 2: Asia-Pacific pharmaceuticals market geography segmentation: % share, by value, 2017

Figure 3: Asia-Pacific pharmaceuticals market share: % share, by value, 2017

Figure 4: Asia-Pacific pharmaceuticals market value forecast: USD billion, 2017-22

Figure 5: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2017

Figure 6: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2017

Figure 7: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2017

Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2017

Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2017

Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2017

Figure 11: Daiichi Sankyo Co Ltd: revenues & profitability

Figure 12: Daiichi Sankyo Co Ltd: assets & liabilities

Figure 13: Shanghai Pharmaceutical Co Ltd: revenues & profitability

Figure 14: Shanghai Pharmaceutical Co Ltd: assets & liabilities

Figure 15: Takeda Pharmaceutical Company Limited: revenues & profitability

Figure 16: Takeda Pharmaceutical Company Limited: assets & liabilities

List of Tables

Table 1: Asia-Pacific pharmaceuticals market value: USD billion, 2013-17

Table 2: Asia-Pacific pharmaceuticals market geography segmentation: USD billion, 2017

Table 3: Asia-Pacific pharmaceuticals market share: % share, by value, 2017

Table 4: Asia-Pacific pharmaceuticals market value forecast: USD billion, 2017-22

Table 5: Daiichi Sankyo Co Ltd: key facts

Table 6: Daiichi Sankyo Co Ltd: key financials (USD )

Table 7: Daiichi Sankyo Co Ltd: key financials (JPY)

Table 8: Daiichi Sankyo Co Ltd: key financial ratios

Table 9: Shanghai Pharmaceutical Co Ltd: key facts

Table 10: Shanghai Pharmaceutical Co Ltd: key financials (USD )

Table 11: Shanghai Pharmaceutical Co Ltd: key financials (CNY)

Table 12: Shanghai Pharmaceutical Co Ltd: key financial ratios

Table 13: Takeda Pharmaceutical Company Limited: key facts

Table 14: Takeda Pharmaceutical Company Limited: key financials (USD )

Table 15: Takeda Pharmaceutical Company Limited: key financials (JPY)

Table 16: Takeda Pharmaceutical Company Limited: key financial ratios

Table 17: Yangtze River Pharmaceutical Group: key facts

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person